Biofarm announced earnings results for the first quarter of 2016. Net profit plunged 52% on the year to RON 6.49 million on the back of unfavourable developments in the local pharmaceutical market. Operating profit was RON 7.99 million compared to RON 16.40 million a year ago. Sales revenue was RON 34.91 million compared to RON 45.78 million a year ago.